Analyzing the Future of Allergy Immunotherapy Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the allergy immunotherapy market?
There’s been a swift expansion in the size of the allergy immunotherapy market in the recent past. The market, set to grow from $2.88 billion in 2024 to $3.17 billion in 2025, forecasts a compound annual growth rate (CAGR) of 10.2%. Factors such as the rising frequency of allergic ailments, advancements in immunotherapy procedures, enhanced patient awareness, government policies, and advancements in research and development have all contributed to the accelerated growth in the historical period.
What will be the allergy immunotherapy market size in the future?
The market for allergy immunotherapy is predicted to expand quickly in the coming years, reaching a value of $5.07 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 12.4%. Factors contributing to this growth during the forecast period are the escalating global allergy burden, supportive healthcare policies, growing acceptance of immunotherapy as well as emerging and untapped markets, and escalating healthcare spending. The forecast period is likely to see trends such as advancements in treatment methodologies, a surge in allergy incidence, the enhancement of patient awareness and education, utilization of telemedicine and remote monitoring, and the development of personalized treatment plans.
Get your allergy immunotherapy market report here!
https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report
What main drivers are fueling expansion in the allergy immunotherapy market?
With the surge in allergic disorders, the allergy immunotherapy market is expected to see significant growth. Allergic disorders are typically extreme immune responses to certain antigens. When immune responses mistakenly target the body’s own components, this can result in autoimmune diseases. Allergy immunotherapy is a treatment option for those with allergy disorders such as IgE-mediated allergic rhinitis and allergic asthma, which are caused by environmental allergens like pollen and house dust mites. For instance, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based regulatory body, English hospitals in August 202 saw over 25,000 admissions due to allergies and anaphylaxis, which was over double the number recorded in the previous two decades. Additionally, the Food Standards Agency, a UK governmental department, published a report in May 2024 indicating that around 6% of adults in the UK, or roughly 2.4 million people, were affected by food allergies according to the Patterns and Prevalence of Adult Food Allergy (PAFA) report. The escalating prevalence of such allergic disorders is thus powering the expansion of the allergy immunotherapy market.
What key areas define the segmentation of the global allergy immunotherapy market?
The allergy immunotherapy market covered in this report is segmented –
1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis
2) By Asthma: Allergic Asthma, Non-Allergic Asthma
3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies
4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies
5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp
Who are the dominant players expanding their reach in the allergy immunotherapy market?
Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.
How are evolving market trends shaping allergy immunotherapy Strategies?
In the allergy immunotherapy market, leading companies are embracing technological innovations, such as artificial intelligence (AI)-based allergy component testing, to maintain their market standing. This AI-driven component testing is a state-of-the-art diagnostic platform used to discern various types of allergies using component resolved diagnostics (CRD). For example, Metropolis Healthcare Limited, a medical laboratory based in India, launched an AI-powered allergy component testing platform in May 2023. This platform, a fourth-generation allergy testing technology, leverages AI assistance for physicians in clinical decision making. It offers profound insights, assists in selection, and optimizes the treatment plan for allergic ailments. Moreover, it possesses the ability to predict the efficacy of immunotherapy for different allergy vaccinations, indicating their effectiveness or inadequacy.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416
Which regions are emerging as leaders in the allergy immunotherapy market?
Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Defibrillator Devices And Equipment Global Market Report 2024
Convalescent Plasma Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
